Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Skin Manifestations
Interventions
DRUG

metronidazole 1% gel

Apply topically on one side of the face once daily for three weeks

DRUG

azelaic acid 15% gel

Apply topically on the opposite side of the face twice daily for three weeks

Trial Locations (1)

75006

Thomas J. Stephens and Associates, Inc., Carrollton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT01139008 - Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin | Biotech Hunter | Biotech Hunter